癌症生物学中的KIF14:对诊断和治疗的影响
Ashok Kumar Bishoyi1, Shaker Al-Hasnaawei2,3, Subbulakshmi Ganesan4
1Department of Microbiology, Faculty of Science, Marwadi University Research Center, Marwadi University, Rajkot, Gujarat, India. ashokkumarbishoyi2@gmail.com.
素家族成员14 (KIF14) 在许多癌症中过度表达,导致瘤生长和对治疗的抗性. 针对KIF14提供了一种有前途的策略,用于治疗侵略性和难以治疗的恶性瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 素家族成员14 (KIF14) 是细胞分裂和细胞内运输至关重要的运动蛋白.
- 过度表达KIF14与多种癌症的不良预后和耐治疗性有关.
- 它在癌症进展中的特定作用需要全面分析.
研究的目的:
- 审查KIF14在癌症进展中的参与.
- 探索KIF14致瘤效应的分子机制.
- 评估KIF14作为预后生物标志物和治疗点.
主要方法:
- 关于KIF14的瘤学研究的综合文献综述14.
- 分析KIF14在细胞循环调节和线粒状形成中的作用.
- 探索KIF14在瘤信号通路中的参与.
主要成果:
- 过度表达KIF14是乳腺癌,卵巢癌,肺癌,肝癌和脑癌的常见特征.
- KIF14有助于瘤的攻击性,不良的临床结果和治疗阻力.
- 它的功能涉及到细胞循环失调和异常的线粒状组装.
结论:
- KIF14是瘤生长和转移的重要驱动因素.
- KIF14有可能成为癌症患者的预后生物标志物.
- 准KIF14为侵袭性癌症提供了一个有希望的治疗途径.
更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
相关概念视频
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
